Stoke Therapeutics Inc buy Chardan Capital
Start price
13.08.25
/
50%
€13.80
Target price
13.08.26
€20.55
Performance (%)
97.10%
Price
11.02.26
€27.20
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Stoke Therapeutics Inc has seen massive gains of 97.10%. This prediction currently runs until 13.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 4.615% | 4.615% |
| iShares Core DAX® | -0.821% | -2.027% |
| iShares Nasdaq 100 | -1.743% | -5.354% |
| iShares Nikkei 225® | 1.215% | 6.383% |
| iShares S&P 500 | -1.167% | -3.462% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
5.43%
11.02.26
11.02.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
203.91%
11.02.26
11.02.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
152.34%
21.12.25
21.12.25